Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Mektovi“
Suchtreffer
Begriffe & Kennungen
Mektovi · 4.8 · In Study CMEK162B2301-Part 2, in the Combo 300 arm, the incidences of liver laboratory abnormalities are liste
Eintrag öffnenMektovi · 4.8 · In patients treated with Combo 450 ISP (n = 372), 230 patients (61.8 %) were < 65 years old, 107 patients (28.
Eintrag öffnenMektovi · 4.8 · Left ventricular dysfunction In the Combo 450 ISP, LVD was reported in 9.4 % (35/372) of patients. Grade 3 eve
Eintrag öffnenMektovi · 4.8 · Liver laboratory abnormalities The incidences of liver laboratory abnormalities reported in the Combo 450 ISP
Eintrag öffnenMektovi · 4.8 · Ocular events In the Combo 450 ISP, RPED was reported in 22.3% (83/372) of patients. RPED was Grade 1 (asympto
Eintrag öffnenMektovi · 4.8 · Palmar-plantar erythrodysaesthesia syndrome PPES can occur when binimetinib is used in combination with encora
Eintrag öffnenMektovi · 4.8 · Pancreatitis Pancreatitis was reported when binimetinib was used in combination with encorafenib (see section
Eintrag öffnenMektovi · 4.8 · Photosensitivity In the Combo 450 ISP, photosensitivity was observed in 4.3% (16/372) of patients. Most events
Eintrag öffnenMektovi · 4.8 · Rash In the Combo 450 ISP, rash occurred in 20.4% (76/372) of patients. Most events were mild, with Grade 3 or
Eintrag öffnenMektovi · 4.8 · Renal dysfunction Blood creatinine elevation and renal failure occurred when binimetinib was used in combinati
Eintrag öffnenMektovi · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenMektovi · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenMektovi · 4.8 · Summary of safety profile
Eintrag öffnenMektovi · 4.8 · Table 3: Adverse reactions occurring in patients receiving binimetinib in combination with encorafenib at the
Eintrag öffnenMektovi · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenMektovi · 4.8 · The safety of binimetinib (45 mg orally twice daily) in combination with encorafenib (450 mg orally once daily
Eintrag öffnenMektovi · 4.8 · The safety of encorafenib (300 mg orally once daily) in combination with binimetinib (45 mg orally twice daily
Eintrag öffnenMektovi · 4.8 · Uveitis was also reported when binimetinib was used in combination with encorafenib (see section 4.8 of encora
Eintrag öffnenMektovi · 4.8 · Venous thromboembolism In the Combo 450 ISP, VTE occurred in 4.8% (18/372) of patients, including 1.9% (7/372)
Eintrag öffnenMektovi · 4.8 · When encorafenib was used at a dose of 300 mg once daily in combination with binimetinib 45 mg twice daily (Co
Eintrag öffnen